About Eurocraze Pharma India Private Limited
Data last updated:
Eurocraze Pharma India Private Limited is a private limited company based in Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 14 March 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U33309DL2020PTC362807. Its GSTIN is 09AAFCE8675B1ZG (Uttar Pradesh).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Dharmendra Singh and Jitendra Singh.
Its last annual general meeting (AGM) was held on 30 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office is at Wb 171 – A G/F Shakarpur Ganesh Nagar 2 Shakarpur, Delhi, India – 110092.
As per the financials filed for FY 2023, the company reported a revenue of ₹26.47 Lakh, a decline of 52% compared to the previous year. For the same year it recorded a net loss of ₹3.67 Lakh (net margin -13.9%) and EBITDA of -₹3.44 Lakh (EBITDA margin -13%).
The company is associated with 1 brand: Eurocraze Pharma India. Court records list 1 case involving the company, including 1 filed against it; 1 case is pending.
For more details, the company can be reached via its website eurocrazepharma.com.
Company details
Contact details
Eurocraze Pharma India Private Limited's registered office is in Delhi, Delhi. Its website is eurocrazepharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressWb 171 – A G/F Shakarpur Ganesh Nagar 2 Shakarpur, Delhi, India – 110092
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Eurocraze Pharma India Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Eurocraze Pharma India operates one associated brand: Eurocraze Pharma India. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Specializes in R&D and manufacturing of drugs for various therapeutic areas. | eurocrazepharma.com |
Business activity
The main business activity of Eurocraze Pharma India is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Eurocraze Pharma India Private Limited, buy the company report.
Financials of Eurocraze Pharma India Private Limited
FY 2023 filings availableEurocraze Pharma India Private Limited reported revenue of ₹26.47 Lakh (down 52% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR)
Revenue fell 52% in the latest year. EBITDA fell 93% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | -₹3.44 Lakh | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | -₹3.67 Lakh | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | -13% | |||
| Net Profit Margin | -13.9% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Eurocraze Pharma India Private Limited, buy the company report.
Board of directors of Eurocraze Pharma India Private Limited
Eurocraze Pharma India has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Dharmendra Singh Also directs: Asterisk Ventures Private Limited | Director | 14 Mar 2020 | 6 Years 7 Months | Current |
| Jitendra Singh Also directs: X-Jars Infratech (India) Private Limited | Director | 14 Mar 2020 | 6 Years 7 Months | Current |
| Sachin Kumar Also directs: X-Jars Infratech (India) Private Limited | Director | 14 Mar 2020 | 6 Years 7 Months | Current |
Peer comparison
Eurocraze Pharma India Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Guturi Pharma Private Limited | ₹26.52 Lakh (FY 2025) | -83.0% | Bangalore, Karnataka, India | |||
| Indianvitamin Formulation Private Limited | ₹26.51 Lakh (FY 2024) | -34.0% | Lucknow, Uttar Pradesh, India | |||
| Eurocraze Pharma India Private Limitedthis company | ₹26.47 Lakh (FY 2023) | -₹3.67 Lakh | -13.9% | -52.0% | Delhi, India | |
| Sritanshi Health Care India Private Limited | ₹26.14 Lakh (FY 2025) | 55.0% | Gorakhpur, Uttar Pradesh, India |
To see the full peer comparison of Eurocraze Pharma India Private Limited, buy the company report.
Auditor
Eurocraze Pharma India Private Limited is audited by GUPTA GOPAL & ASSOCIATES for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| GUPTA GOPAL & ASSOCIATES | FY 2021 | 009968C |
Shareholding
The shareholding of Eurocraze Pharma India Private Limited is on record for FY 2021, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2021 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Public | |
| Others |
To see the full shareholding pattern of Eurocraze Pharma India Private Limited, buy the company report.
Legal cases
Eurocraze Pharma India Private Limited has 1 court case on record: 1 filed against it. All case is pending.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 1 | 1 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Chandigarh | Cheque dishonour complaint | Filed against the company by M/S Theon Pharmaceuticals Ltd | Pending |
To see the full case history of Eurocraze Pharma India Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Eurocraze Pharma India Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Eurocraze Pharma India has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAFCE8675B1ZG | Uttar Pradesh | Active | 01 Jun 2020 |
To see the full GST registrations and return filing status of Eurocraze Pharma India Private Limited, buy the company report.
Recent activity
Eurocraze Pharma India Private Limited has 3 board changes on record since 2020: 3 appointments. The latest: Dharmendra Singh was appointed as Director on 14 Mar 2020.
Frequently asked questions
Eurocraze Pharma India is an active private limited company based in Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 14 March 2020 (6+ years old) and is registered under CIN U33309DL2020PTC362807.
Eurocraze Pharma India has 3 current directors:
- Dharmendra Singh - Director
- Jitendra Singh - Director
- Sachin Kumar - Director
The latest financial statements of Eurocraze Pharma India on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 30 September 2023. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Eurocraze Pharma India is 09AAFCE8675B1ZG, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Eurocraze Pharma India is U33309DL2020PTC362807. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Eurocraze Pharma India has 1 court case on record: 1 filed against it. 1 is pending.
Eurocraze Pharma India was incorporated on 14 March 2020, making it 6+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Eurocraze Pharma India by revenue are Guturi Pharma Private Limited, Indianvitamin Formulation Private Limited, Sritanshi Health Care India Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (wholesale trading).
Dharmendra Singh was appointed as Director on 14 Mar 2020. Jitendra Singh was appointed as Director on 14 Mar 2020. Sachin Kumar was appointed as Director on 14 Mar 2020.
Eurocraze Pharma India can be reached through the website eurocrazepharma.com. Its registered office is in Delhi, India.
The registered office of Eurocraze Pharma India is at Wb 171 – A GF Shakarpur Ganesh Nagar 2 Shakarpur, Delhi, India – 110092.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
